December 26, 2005 -- Last week, Osiris Therapeutics, of Baltimore, MD closed a $19 million private placement equity round. The money will fund the company’s five ongoing clinical trial programs, which use a proprietary adult stem cell therapy. We look at recent clinical milestones of Osiris, its backers and its use of stem cells...